Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes

By Jonsson Malin KB   van Veen Toon AB   Goumans Marie-Jose   Vos Marc A   Duker Göran   Sartipy Peter  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 357-372

Informa Healthcare

Access to resources Recommend Favorite

Human embryonic stem cell-derived cardiomyocytes: drug discovery and safety pharmacology

By He Jia-Qiang   January Craig T   Thomson James A   Kamp Timothy J  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 739-753

Informa Healthcare

Access to resources Recommend Favorite

Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery

By  

Current Medicinal Chemistry, Vol. 23, Iss. 30, 2016-10 ,pp. : 3495-3509

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Target Pharmacogenomics: The potential to revolutionize drug discovery and development

By  

Pharmaceutical Innovation, Vol. 11, Iss. 4, 2002-06 ,pp. : 30-37

Adis International

Access to resources Recommend Favorite

Stem Cell Lineage Commitment by Electrical Fields and the Potential Application in Drug Discovery

By  

Current Drug Metabolism, Vol. 14, Iss. 3, 2013-03 ,pp. : 272-278

Bentham Science Publishers

Access to resources Recommend Favorite